Bladder urothelial carcinoma (BLCA)
Breast invasive carcinoma (BRCA)
Cervical and endocervical cancers (CESC)
Colon adenocarcinoma (COAD)
Esophageal carcinoma (ESCA)
Glioblastoma multiforme (GBM)
Head and Neck squamous cell carcinoma (HNSC)
Kidney renal clear cell carcinoma (KIRC)
Kidney renal papillary cell carcinoma (KIRP)
Acute Myeloid Leukemia (LAML)
Brain Lower Grade Glioma (LGG)
Liver hepatocellular carcinoma (LIHC)
Lung adenocarcinoma (LUAD)
Lung squamous cell carcinoma (LUSC)
Ovarian serous cystadenocarcinoma (OV)
Pancreatic adenocarcinoma (PAAD)
Pheochromocytoma and Paraganglioma (PCPG)
Prostate adenocarcinoma (PRAD)
Rectum adenocarcinoma (READ)
Sarcoma (SARC)
Skin Cutaneous Melanoma (SKCM)
Stomach adenocarcinoma (STAD)
Testicular Germ Cell Tumors (TGCT)
Thyroid carcinoma (THCA)
Thymoma (THYM)
Uterine Corpus Endometrial Carcinoma (UCEC)
GLYATL1 is not expressed in BLCA.